Exchange
Last Trade
Change
Change Percent
Volume
Pricing delayed 15 minutes

Webcast Leerink Swann 2012 Global Healthcare Conference Syneron Investor Presentation – February 2012 Q4 2011 Results 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference

Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company’s technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring,  hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela.  Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel.  Syneron also has R&D and manufacturing operations in the US.  The company markets, services and supports its products in 86 countries.  It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide. Additional information can be found at www.syneron.com

Recent News
Feb 15 2012	Clinical Study on Skin Lightening With elure(TM) Published in the Journal of Cosmetic Dermatology Shows Significant Superiority in Safety, Effectiveness and Time to Achieve Improved Skin Pigmentation When Compared to the Current Prevalent Skin Lightening Product
Feb 14 2012	Syneron to Present the New GentleMax Pro(R) at the 2012 South Beach Symposium
Feb 09 2012	Syneron Reports Fourth Quarter 2011 Results
Feb 08 2012	Syneron to Acquire Ultrashape Ltd.

Contact IR

Feel free to contact us using the message form here.
Be sure to include your contact information if you are requesting a response.